CN Patent

CN101405031A — 用于胃肠外递送化合物的配制物和其用途

Assigned to Wyeth LLC · Expires 2009-04-08 · 17y expired

What this patent protects

本发明提供了实现有效递送甲基纳曲酮组合物的配制物。所提供的配制物用于预防、治疗、延迟、减少使用镇痛阿片类所导致的副作用或降低其严重程度。

USPTO Abstract

本发明提供了实现有效递送甲基纳曲酮组合物的配制物。所提供的配制物用于预防、治疗、延迟、减少使用镇痛阿片类所导致的副作用或降低其严重程度。

Drugs covered by this patent

methylnaltrexone-bromide (METHYLNALTREXONE BROMIDE)

Patent Metadata

Patent number: CN101405031A
Jurisdiction: CN
Classification: —
Expires: 2009-04-08
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.